Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The surgical implications of the posttransplant lymphoproliferative disorders.

Literature DB >> 1989270

The surgical implications of the posttransplant lymphoproliferative disorders.

A O Stieber¹, O Boillot, C Scotti-Foglieni, M A Nalesnik, R D Gordon, I Marino, V Mazzaferro, T E Starzl.

Abstract

Entities: Disease

Mesh：

Substances：
Immunosuppressive Agents

Year: 1991 PMID： 1989270 PMCID： PMC3084540

Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066

× No keyword cloud information.

10 in total

Review 1. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation.

Authors: D W Hanto; G Frizzera; K J Gajl-Peczalska; R L Simmons
Journal: Transplantation Date: 1985-05 Impact factor: 4.939

Review 2. The diagnosis and treatment of posttransplant lymphoproliferative disorders.

Authors: M A Nalesnik; L Makowka; T E Starzl
Journal: Curr Probl Surg Date: 1988-06 Impact factor: 1.909

Review 3. Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy.

Authors: T E Starzl; I Penn; C W Putnam; C G Groth; C G Halgrimson
Journal: Transplant Rev Date: 1971

4. De novo malignant tumors in organ transplant recipients.

Authors: I Penn; C G Halgrimson; T E Starzl
Journal: Transplant Proc Date: 1971-03 Impact factor: 1.066

5. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

Authors: T E Starzl; M A Nalesnik; K A Porter; M Ho; S Iwatsuki; B P Griffith; J T Rosenthal; T R Hakala; B W Shaw; R L Hardesty
Journal: Lancet Date: 1984-03-17 Impact factor: 79.321

6. Clonal characteristics of posttransplant lymphoproliferative disorders.

Authors: M A Nalesnik; J Locker; R Jaffe; A J Demetris; K Hartle; J A Burnham; L Makowka; T E Starzl
Journal: Transplant Proc Date: 1988-02 Impact factor: 1.066

7. Lymphoma in renal allograft patients treated with cyclosporin-A as one of the immunosuppressive agents.

Authors: S Thiru; R Y Calne; J Nagington
Journal: Transplant Proc Date: 1981-03 Impact factor: 1.066

8. Malignant lymphomas in transplantation patients.

Authors: I Penn; W Hammond; L Brettschneider; T E Starzl
Journal: Transplant Proc Date: 1969-03 Impact factor: 1.066

9. Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

Authors: D W Hanto; K J Gajl-Peczalska; G Frizzera; D C Arthur; H H Balfour; K McClain; R L Simmons; J S Najarian
Journal: Ann Surg Date: 1983-09 Impact factor: 12.969

Review 10. Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model.

Authors: D T Purtilo
Journal: Adv Cancer Res Date: 1981 Impact factor: 6.242